Literature DB >> 30374634

Compromised vitality of spermatozoa after contact with colonic mucosa in mice: implications for fertility in colon vaginoplasty patients.

Seitaro Kosaka1, Masahiro Takeda2, Takanori Ochi2, Katsumi Miyahara2, Eri Nakamura3, Norihiro Tada3, Geoffrey J Lane2, Atsuyuki Yamataka2.   

Abstract

AIM OF THE STUDY: Colon vaginoplasty (CV) is often performed for cloacal malformation (CM). We used mice to study the vitality of spermatozoa after contact with colonic mucosa as a factor contributing to infertility.
METHODS: Spermatozoa isolated from the epididymides of C57BL/6J male mice (n = 23) were syringed directly into the vaginas (Vag-group) or colons (Colo-group) of female mice (n = 45). Vitality was determined by assessing motility using computer-assisted sperm analysis, viability by staining with SYBR-14 and propidium iodide, and fertility by in vitro fertilization, prior to deposition, and at 5, 10, 30, and 60 min after deposition. MAIN
RESULTS: Motility was significantly decreased in Colo only at 10 and 60 min. Viability of Colo spermatozoa was significant at all assessment times, except at 10 min. Normal fertilization was observed with all Vag spermatozoa, but with Colo, there was arrest of embryo development with spermatozoa collected at 5 and 10 min, and no fertilization with spermatozoa collected at 30 and 60 min.
CONCLUSIONS: The vitality of spermatozoa is compromised by contact with colonic mucosa which could contribute to infertility in CM after CV, because their ovaries and fallopian tubes are considered to be normal.

Entities:  

Keywords:  Cloacal malformation; Colon vaginoplasty; Infertility; Spermatozoa

Mesh:

Year:  2018        PMID: 30374634     DOI: 10.1007/s00383-018-4377-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  17 in total

1.  A case of successful pregnancy outcome in a patient born with cloacal malformation.

Authors:  N Salvi; I Arthur
Journal:  J Obstet Gynaecol       Date:  2008-04       Impact factor: 1.246

2.  Evaluation of chromosomal risk following intracytoplasmic sperm injection in the mouse.

Authors:  Hiroyuki Tateno; Yujiroh Kamiguchi
Journal:  Biol Reprod       Date:  2007-04-04       Impact factor: 4.285

3.  Cloacal malformations: lessons learned from 490 cases.

Authors:  Marc A Levitt; Alberto Peña
Journal:  Semin Pediatr Surg       Date:  2010-05       Impact factor: 2.754

4.  Hyper-activated motility in sperm capacitation is mediated by phospholipase D-dependent actin polymerization.

Authors:  Sarit Bar-Sheshet Itach; Maya Finklestein; Nir Etkovitz; Haim Breitbart
Journal:  Dev Biol       Date:  2011-12-08       Impact factor: 3.582

Review 5.  Clinical implications of uterine malformations and hysteroscopic treatment results.

Authors:  G F Grimbizis; M Camus; B C Tarlatzis; J N Bontis; P Devroey
Journal:  Hum Reprod Update       Date:  2001 Mar-Apr       Impact factor: 15.610

Review 6.  Reproductive performance of women with müllerian anomalies.

Authors:  Beth W Rackow; Aydin Arici
Journal:  Curr Opin Obstet Gynecol       Date:  2007-06       Impact factor: 1.927

7.  Long-term gynecological outcome of patients with persistent cloaca.

Authors:  S A Warne; D T Wilcox; S Creighton; P G Ransley
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

8.  In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos.

Authors:  Evangelos G Papanikolaou; Michel Camus; Efstratios M Kolibianakis; Lisbet Van Landuyt; Andre Van Steirteghem; Paul Devroey
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

9.  Surgical management of cloacal malformations: a review of 339 patients.

Authors:  Alberto Peña; Marc A Levitt; Andrew Hong; Peter Midulla
Journal:  J Pediatr Surg       Date:  2004-03       Impact factor: 2.545

10.  Sperm freezing and in vitro fertilization in three substrains of C57BL/6 mice.

Authors:  Ling Liu; Lauryl M J Nutter; Napoleon Law; Colin McKerlie
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-01       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.